Contract Manufacturing

The U.K. government has put a manufacturing plant up for sale that was instrumental in the country’s plan to battle future pandemics. According to The Financial Times, the plant, dubbed the Vaccine Manufacturing Innovation Centre (VMIC), had received at least £215 million of public funding since it was launched in 2018. A handful of companies…

Baxter International (NYSE:BAX) plans to invest roughly $100 million to expand a sterile fill-finish manufacturing plant in Halle/Westfalen, Germany. BioPharma Solutions (BPS), a subsidiary of Deerfield, Illinois–based Baxter, will manage the new facility. BPS supports pharmaceutical companies through a range of offerings, including scientific support, sterile contract manufacturing and parenteral delivery systems. Baxter anticipates that…

Emergent BioSolutions (NYSE:EBS) saw its stock plunge today after the U.S. nixed a contract to manufacture COVID-19 vaccine doses for Johnson & Johnson (NYSE:JNJ). Earlier this year, the company disposed of tens of millions of COVID-19 vaccine doses after identifying a manufacturing error in a Baltimore plant. FDA released a scathing inspection report related to…

Merck KGaA, Darmstadt, Germany, will collaborate with Riyadh, Saudi Arabia-headquartered SaudiVax to design a manufacturing plant to produce biologics and vaccines for the Middle East and North Africa. Merck KGaA will also provide its integrated Contract Development Manufacturing Services as part of the partnership. SaudiVax intends to be the first Saudi company to manufacture halal…

Catalent (NYSE:CTLT) shares dipped today despite first-quarter financial results that beat the consensus forecast. The Somerset, New Jersey-based company posted profits of $93 million, or 49¢ per share, on sales of $1.025 billion for the three months ended Sept. 30, 2021, for a 13.4% bottom-line gain on sales growth of 21.2%. Adjusted to exclude one-time…

AbbVie (NYSE:ABBV) shares ticked up before hours today on third-quarter results that beat the consensus forecast. The North Chicago, Illinois-based company posted profits of $3.2 billion, or $1.78 per share, on sales of $14.34 billion for the three months ended Sept. 30, 2021, for a 37.5% bottom-line gain on sales growth of 11.2%. Adjusted to…

Merck (NYSE:MRK) shares ticked up today on third-quarter results that beat the consensus forecast. The company also announced that it projects its oral COVID-19 antiviral molnupiravir to bring in between $5 billion and $7 billion in revenue next year. MRK shares were up 4.9% at $85.55 per share in early-morning trading today. MassDevice’s MedTech 100…

Novartis (NYSE:NVS) has announced that it has reached an agreement with BioNTech (NSDQ:BNTX) and Pfizer (NYSE:PFE) to produce their popular COVID-19 BNT162b2 vaccine. The companies reached a new production agreement that will leave Novartis responsible for fill-and-finish operations related to the mRNA-based vaccine from Pfizer and BioNTech. Under the agreement, Novartis will produce at least…

To fast-track the time to market and gain a competitive edge, pharmaceutical development companies are increasingly implementing single-use technologies (SUT). Single-use technologies are built using an array of components, including sampling bottles, filters, Luer locks, seals and dispensing tips. The technology can be as simple as a single assembly. Or it can be an entire…

STERIS (Menton, Ohio) and H+E Pharma (Stuttgart, Germany) will collaborate on designing, installing and maintaining utility water systems for the pharma sector and other life science applications in Europe. The partnership will provide end-to-end, turnkey clean utility water systems. “We can now provide our broad portfolio of Finn-Aqua products, alongside H+E’s engineering expertise to offer…